Grant Reference Clause Samples

A Grant Reference clause establishes a formal acknowledgment of the funding or support provided by a grant within a contract or agreement. This clause typically requires the recipient to cite the grant in any publications, reports, or public communications resulting from the funded work, and may specify the exact wording or format for such references. Its core practical function is to ensure that the grantor receives proper recognition for their contribution, promoting transparency and accountability in the use of grant funds.
POPULAR SAMPLE Copied 1 times
Grant Reference. In all notices, requests, reports or correspondence in connection with Grant funding, the following number should appear on any such document as the grant reference: GR06JOR09001.
Grant Reference. The Government shall include the grant reference number provided by MCC on all notices, requests, reports or correspondence in connection with the Grant funding.
Grant Reference. In the event that the Permitted Designee undertakes the procurement or implementation of any Government-Contracted Activities, MCC shall send a Grant reference number to the Government and its Permitted Designee. The Grant reference number sent by MCC should appear on all subsequent notices, requests, reports or other correspondence in connection with the Grant funding.
Grant Reference. 16 Exhibit A: Index of Definitions Annex I: Description of the Assistance Annex II: Tax Procedures ▇▇▇▇▇▇▇ ▇▇▇▇▇ AND IMPLEMENTATION AGREEMENT GRANT AND IMPLEMENTATION AGREEMENT This GRANT AND IMPLEMENTATION AGREEMENT (this “Agreement”), dated as of July 13, 2012, is made by and between the Millennium Challenge Corporation, a United States Government corporation (“MCC”), and the Government of Georgia (the “Government”), acting through the Ministry of Finance (the “Ministry”). The Government and MCC are referred to herein as the “Parties” and each, individually, a “Party.”

Related to Grant Reference

  • Right of Reference Section 1: If the two Parties fail to agree upon an interpretation of the Agreement, either Party shall have the right to refer the matter to the Joint Industry Committee, hereinafter provided, and if either party does make such reference, the other Party must accept the reference. Section 2: The Joint Industry Committee shall consist of three (3) representatives selected by the USW. Negotiating Committee and three (3) representatives selected by the Employers represented in the negotiations of this Agreement, and the two (2) committees may be represented by one (1) or more Parties selected by them. Section 3: When an interpretation of the Agreement has been referred to the Joint Committee, this reference shall be for the period of forty-eight (48) hours or longer by mutual consent of the Parties to this Agreement. In case the Joint Committee agrees upon a recommendation or interpretation, this shall be furnished in writing to the Union involved and to the Employer. Section 4: In the event the Joint Committee members disagree, all the facts in the case as found by the Union and Union members of the Joint Committee shall be placed in writing by the Union representatives and submitted to the Employer and to the Union Members involved. The facts in the case as found by the Employer and the employer members of the Joint Committee shall be placed in writing and given to the Union member employees for their information. Section 5: If a satisfactory interpretation of the point in question is not reached, either Party may refer the question to arbitration as hereinafter provided.

  • EMPLOYMENT REFERENCES D3.01 On application by an employee, the Employer shall provide personal references to the prospective employer of such employee, indicating length of service, principal duties and responsibilities, and performance of such duties.

  • Terms of Reference The SSEC shall update, not later than January 31, 2023, the terms of reference for the committee. If no such agreement can be reached the SSEC shall make recommendations to the Provincial Labour Management Committee (PLMC). Commencing July 1, 2022, there will be $50,000 of annual funding allocated for the purposes set out above. Commencing July 1, 2024, there will be an additional $1,000,000 of annual funding allocated for the purposes set out above.

  • HEADING REFERENCES Section headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose. References to “this Agreement” or the use of the term “hereof” shall refer to these Standard Terms and Conditions and the Employment Agreement attached hereto, taken as a whole.

  • Rights of Reference Upon mutual agreement, Regeneron will grant to the Government a right of reference to any Regulatory Application submitted in support of this Project Agreement, solely for the purpose of the Government conducting a clinical trial with the drug product supplied under this Project Agreement under a protocol approved by Regeneron for performance by the Government. In such a case, Regeneron agrees to provide a letter of cross-reference to the Government and file such letter with the appropriate FDA office. Nothing in this paragraph reduces the Government’s data rights as articulated in other provisions of this award.